DAAN Bio Therapeutics announced that it has received KRW 23,000,000,000 in round of funding co-led by new investors Solasta Ventures, Inc, Paratus Investment Inc., Timefolio Asset Management Co.,Ltd, Company K Partners Limited, Atinum Investment Co., Ltd, Stonebridge Ventures, DAYLI Partners Co., Ltd., KB Investment Co., Ltd, Solidus Investment Co., Ltd., Heungkuk Securities Co., Ltd., Shinhan Capital Co., Ltd. and FuturePlay on January 29, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,950 KRW | -1.28% | +0.58% | +4.20% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
6,950 KRW | -1.28% | +0.58% | 81.21M | ||
3,005 KRW | +1.35% | +2.74% | 103M | ||
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+4.20% | 81.21M | |
+14.61% | 3.05B | |
+12.82% | 2.06B | |
+8.43% | 1.51B | |
-11.54% | 1.2B | |
+11.49% | 756M | |
+28.93% | 570M | |
-4.17% | 503M | |
+29.04% | 466M | |
+3.90% | 309M |
- Stock Market
- Equities
- A307930 Stock
- News Company K Partners Limited
- DAAN Bio Therapeutics announced that it has received KRW 23 billion in funding from a group of investors